Crispr Therapeutics Ag (CRSP)

Other Income/Expenses (Net)

$24.60M

Quarterly · Period ending: · USD

CRSP logo

CRSP Other Income/Expenses (Net)

Latest reported$24.60M
CRSP Quarterly Other Income/Expenses (Net) (-$71.00K → $24.60M)
High-resolution chart · PNG

CRSP other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Crispr Therapeutics Ag Other Income/Expenses (Net) — Quarterly (USD)
Period endingOther Income/Expenses (Net) (USD)
24,602,000
8,156,000
24,765,000
26,237,000
-74,186,000
13,537,000
27,977,000
25,064,000
26,139,000
24,720,000
19,997,000
20,671,000
18,406,000
12,742,000
11,490,000
7,264,000
3,544,000
363,000
6,702,999
1,101,000
750,000
1,955,000
868,999
160,000
1,412,000
4,232,000
19,563,000
-466,000
1,369,000
100,000
-2,128,000
-1,142,000
-998,000
-1,217,000
-412,000
-430,000
-666,000
-452,000
42,808,000
-76,000
-606,000
3,286,000
-50,000
1,000
28,000
-71,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.